Showing 3 results for Bonakdar
Maryam Khajavi, Abdolmajid Hajimoradloo, Mojgan Zandi, Mohamad Pezeshki-Modaress, Abbas Zamani, Shahin Bonakdar,
Volume 9, Issue 3 (8-2020)
Abstract
Controlled delivery technology of protein/peptide drugs from biodegradable particles has emerged as one of the eminent areas to overcome problems related to macromolecules formulation. The goal of the present study was to develop protein-loaded micro-particles using biodegradable polymer, polycaprolactone (PCL) and hydrogel from beluga cartilage. Bovine serum albumin (BSA) was used as a model for protein/ peptide molecules such as GnRH. The double emulsion (W/O/W) technique was selected as one of the most appropriate methods for preparing a drug delivery system for soluble proteins in water. The first emulsion was prepared using ultrasonic and the mechanical agitator was used for achieving the second emulsion. The hydrogel prepared by enzymatic digestion was used in the first aquatic solution. At the present investigation, three groups were considered as the drug delivery system: G1; (PCL/hydrogel/BSA), G2; (PCL/BSA) and G3; (PCL/Alginate/BSA). Findings showed that the morphology of particles was spherical and non-conglomerated in all groups. The comparison of average particle size among groups was also indicated that the particles.
Volume 16, Issue 5 (ویژه نامه- 2016)
Abstract
In open channels, the distribution of velocity, shear stress and other related quantities such as the diffusion and dispersion coefficients and thus all transport processes are three-dimensional, according to the three-dimensional convection and diffusion principles. Determining the velocity distribution- as a key parameter for estimating other hydraulic parameters- has always been the subject of attention. Velocity distribution in the inner region of the flow (y0.2D). The log-Wake law is of the most accepted laws for velocity distribution in wide open channels, this law modifies the logarithmic law by adding a Wake function; but in case of narrow open channels, the log-Wake law deviates from the measured data near the free surface. Because the profile by the log-Wake law depicts the velocity which increases with the increase of distance from the bed monotonically and is not able to show the velocity negative gradient near the free surface which happens in narrow open channels. In narrow open channels, the three dimensional structure of the flow and the transport momentum from the side walls to the central zone due to strong secondary currents, causes the maximum velocity to occur below the water surface which is called velocity-dip phenomenon. The velocity dip phenomenon was first reported more than a century ago. Since that time, numerous investigations have been conducted by many researchers in order to propose new models to be able to not only describe the dip phenomenon and negative gradient of velocity near the free surface, but also to predict the position of the maximum velocity accurately and fit the experimental data throughout the whole flow depth.
This paper introduces an analytical model based on Reynolds Averaged Navier Stokes (RANS) equations and an eddy viscosity distribution, to estimate velocity distribution in turbulent fully developed flows. The proposed model is suitable for both narrow and wide open channels, and is capable of predicting the dip phenomenon. The results by the model verified with data measured in several rectangular lab channels and data collected from an actual sewer channel. Since the proposed equation for velocity distribution is dependent of Coles Wake parameter (Π), the effect of this parameter on level of accuracy and description of velocity profile as well as prediction of dip phenomenon and location of maximum velocity has been studied. Many researchers proposed different values for Coles parameter, and it seems there is no universal constant value for this parameter. In this study, the value of Coles parameter was proposed by fitting the data from different channels, based on the least error calculated in predicting the velocity profiles by the proposed model. The results show that the profiles by the model agree well with experimental data and predict the velocity-dip phenomenon; also the model provides little errors compared to measured data in the channels, which is representative of high level of accuracy in defining velocity distribution profile of the flow. The value of Coles parameter estimated for channel-sewer was less than that for lab channels.
Volume 21, Issue 1 (Spring 2018)
Abstract
Introduction: Cartilage is a tissue without vessel and lymph in body. If it has a massive defect, it cannot regenerate and reconstruct itself. In this society, cartilage diseases such as osteoarthritis and cartilage defects have increased. Its defects can disrupt the daily function of the patient and can be accompanied by pain due to bone wear. Common methods used to treat cartilage defects, which are considered invasive with low efficacy, include autologous chondrocytes, microfracture, bone marrow stimulation, and debridement. Current treatments are not definitive methods, which is why the use of stem cells and cartilage tissue engineering has been turned on. In the current review, the types of stem cells used in cartilage therapy and cartilage tissue engineering were investigated. Then, cellular signaling factors such as growth factors, mechanical and environmental factors were mentioned and referred to scaffolds based on the biomaterials used to engineer high-efficiency stem cells for the reconstruction of cartilage tissue. Therefore, the aim of this study was to review the use of stem cells in cartilage tissue regeneration and engineering.
Conclusion: The role of stem cells in regeneration of cartilage has been properly proven, but the mechanism and method of creating this regeneration has not yet been determined. Mesenchymal cells have the highest safety in cell therapy in cartilage, and these types of cells have the most clinical usage. In Iran, cell therapy is performed clinically for patients, but cartilage tissue engineering has not yet reached the clinical stage.